Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Closed
Net new
Funds Holding
2,745
Funds Holding Change
+189
Funds Holding Growth
+7%
Value
$938B
Holding in Top 10
1,224
Top 10 Change
+10
Top 10 Growth
+0.8%
Value Growth
+1%
New
285
Increased
1,162
Reduced
1,175
Closed
66
Capital Inflow
$36.3B
Capital Outflow
$39.9B
Net Capital Flow
-$3.63B
Capital Flow Change
+$7.77B
Calls
$13B
Puts
$15.5B
Net Calls
-$2.48B
Put/Call Ratio
1.19